Pharma & Biotech

Biotechnology firm Karyopharm Therapeutics finds itself navigating turbulent market conditions as its stock experiences a significant technical breakdown. The company's...

The biotechnology sector has identified its latest standout performer: Adma Biologics. This plasma-derived therapy specialist is commanding significant market attention,...

The German biotechnology firm BioNTech is on the verge of a significant strategic achievement, having successfully navigated the primary hurdle...

A dramatic reassessment is underway for Intellia Therapeutics, sending shockwaves through the biotech investment community. Market research firm Morningstar has...

Shares of medical technology firm SI-Bone have surged approximately 55% over the past year, nearly touching their 52-week high of...

A dramatic strategic shift appears to be paying off for Novavax, as the biotech firm moves away from a high-risk...

Biopharmaceutical firm Ocugen approaches a potentially transformative event as it prepares to present at the NobleCon21 conference on December 3,...

As US markets remain closed for the Thanksgiving holiday, shares of Viking Therapeutics are enjoying a brief respite. The stock...

The European biotech landscape is poised for a significant transformation as BioNTech approaches the final stages of its planned acquisition...

Investors in Danish pharmaceutical giant Novo Nordisk experienced a rollercoaster week, marked by a significant clinical setback swiftly followed by...